Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin in Blepharospasm
NCT00406367Phase 3Completed
- Sponsor
- Merz
- Start
- Oct 2006
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of incobotulinumtoxinA in benign essential blepharospasm (BEB), sponsored by Merz. Started Oct 2006; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT00406367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406367.